MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients
Clinical trial NCT04212221 · TERMINATED
Trial details
- NCT number
- NCT04212221
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-20
- Primary completion
- 2022-04-27
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.